Schellenberg Wittmer advised Julius Baer Group Ltd on the deal. Julius Baer has decided to sell Geneva-based Fransad Gestion SA (Fransad) to the management team of the...
Julius Baer Group Ltd’s Sale of Fransad Gestion SA
Alpian’s Obtention of Its FINMA Banking Licence
Schellenberg Wittmer advised Alpian on the deal. In April 2020, Swiss financial technology company Alpian SA applied for a full banking licence from the Swiss Financial Market...
Kinarus’ Transaction Agreement With Perfect Holding
Schellenberg Wittmer advised Kinarus in this transaction. Kinarus, a privately owned clinical-stage biopharmaceutical company active in the development of novel treatments for patients suffering from serious viral,...
Francotyp-Postalia’s Acquisition of Azolver
DLA Piper and Schellenberg Wittmer advised Francotyp-Postalia Holding AG on the deal. Bird & Bird, Selmer and Homburger advised Azolver Holding. Francotyp-Postalia Holding AG (FP) executed...
Helvetia’s Acquisition of Minority Stake in MoneyPark
Schellenberg Wittmer advised Helvetia on the deal. The media group TX Group sold its shares in Moneypark to the insurer Helvetia. Mr. Heitmann will remain a...
Arsenal Capital Partners’ Acquisition of ATP Group
Schellenberg Wittmer advised Arsenal Capital Partners on the deal, in cooperation with Jones Day. Bär & Karrer advised Bregal, together with Latham & Watkins. Baker McKenzie...
Credit Suisse’s Plan To Exit Nine Non-Core Wealth Management Markets in The SSA
Schellenberg Wittmer advised Credit Suisse on the deal. Credit Suisse announced its private banking client referral agreement with Barclays as part of the plan to exit nine...
LLB’s Tender Offer to Fully Acquire Its 75% Bank Linth
Bär & Karrer advised LLB in this transaction. Schellenberg Wittmer advised Bank Linth. Liechtensteinische Landesbank AG (LLB) intends to increase the shareholding in its subsidiary Bank...
Santhera Pharmaceuticals’ License Agreement With Sperogenix Therapeutics
chellenberg Wittmer advised Santhera Pharmaceuticals on the deal. Swiss Biotech Santhera has entered an exclusive licence agreement with China-based Sperogenix Therapeutics for the development of Vamorolone...
Julius Baer Group Ltd’s Sale of Wergen & Partner Wealth Management Ltd
Schellenberg Wittmer advises Julius Baer Group Ltd on the deal. Julius Baer has agreed to sell Wergen & Partner Wealth Management to its management. The parties...
LaPreva’s Acquisition of Closomat Service Business From Closemo
Schellenberg Wittmer advised LaPreva on the deal. LaPreva, a Swiss leading expert in the design and manufacturing of shower-toilets, announced the acquisition of the customer base and...
Carify’s Financing Round
Schellenberg Wittmer advised Carify on the deal. Advestra advised Zurich Insurance Company Ltd. The Switzerland’s largest car subscription platform Carify completed its recent equity financing. Investors in...